Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06660654
Title	A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
Recruitment	Not yet recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Daiichi Sankyo
Indications	uterine carcinosarcoma endometrial carcinoma cervical adenocarcinoma renal pelvis transitional cell carcinoma ovarian clear cell carcinoma ovarian serous carcinoma cervical adenosquamous carcinoma endometrioid ovary carcinoma cervical squamous cell carcinoma ureter transitional cell carcinoma bladder urothelial carcinoma clear cell renal cell carcinoma ovarian mucinous neoplasm transitional cell carcinoma urethra transitional cell carcinoma
Therapies	Raludotatug deruxtecan
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Clinical Research Alliance		Westbury	New York	11590	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field